302 related articles for article (PubMed ID: 21936502)
21. Strategies for siRNA navigation to desired cells.
Sioud M
Methods Mol Biol; 2015; 1218():201-16. PubMed ID: 25319653
[TBL] [Abstract][Full Text] [Related]
22. Construction of an Aptamer-SiRNA Chimera-Modified Tissue-Engineered Blood Vessel for Cell-Type-Specific Capture and Delivery.
Chen W; Zeng W; Sun J; Yang M; Li L; Zhou J; Wu Y; Sun J; Liu G; Tang R; Tan J; Zhu C
ACS Nano; 2015 Jun; 9(6):6069-76. PubMed ID: 26051465
[TBL] [Abstract][Full Text] [Related]
23. Peptide-Aptamer Coassembly Nanocarrier for Cancer Therapy.
Ma Y; Li W; Zhou Z; Qin X; Wang D; Gao Y; Yu Z; Yin F; Li Z
Bioconjug Chem; 2019 Mar; 30(3):536-540. PubMed ID: 30702869
[TBL] [Abstract][Full Text] [Related]
24. Effect of nanoparticle conjugation on gene silencing by RNA interference.
Singh N; Agrawal A; Leung AK; Sharp PA; Bhatia SN
J Am Chem Soc; 2010 Jun; 132(24):8241-3. PubMed ID: 20518524
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA.
Wilner SE; Levy M
Methods Mol Biol; 2016; 1380():211-24. PubMed ID: 26552829
[TBL] [Abstract][Full Text] [Related]
26. Aptamer-siRNA chimeras: Promising tools for targeting HER2 signaling in cancer.
Dhanya CR; Mary AS; Madhavan M
Chem Biol Drug Des; 2023 May; 101(5):1162-1180. PubMed ID: 36099164
[TBL] [Abstract][Full Text] [Related]
27. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.
Dassie JP; Liu XY; Thomas GS; Whitaker RM; Thiel KW; Stockdale KR; Meyerholz DK; McCaffrey AP; McNamara JO; Giangrande PH
Nat Biotechnol; 2009 Sep; 27(9):839-49. PubMed ID: 19701187
[TBL] [Abstract][Full Text] [Related]
28. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
[TBL] [Abstract][Full Text] [Related]
29. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
Catuogno S; Esposito CL; Giangrande PH
Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
[TBL] [Abstract][Full Text] [Related]
30. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
Kruspe S; Giangrande PH
Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
[TBL] [Abstract][Full Text] [Related]
31. Aptamer-mediated nanoparticle-based protein labeling platform for intracellular imaging and tracking endocytosis dynamics.
Chen LQ; Xiao SJ; Hu PP; Peng L; Ma J; Luo LF; Li YF; Huang CZ
Anal Chem; 2012 Apr; 84(7):3099-110. PubMed ID: 22423600
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
[TBL] [Abstract][Full Text] [Related]
33. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy.
Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T
Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060
[TBL] [Abstract][Full Text] [Related]
34. DNA tetrahedron-based nanogels for siRNA delivery and gene silencing.
Xue H; Ding F; Zhang J; Guo Y; Gao X; Feng J; Zhu X; Zhang C
Chem Commun (Camb); 2019 Apr; 55(29):4222-4225. PubMed ID: 30896698
[TBL] [Abstract][Full Text] [Related]
35. Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells.
Ayatollahi S; Salmasi Z; Hashemi M; Askarian S; Oskuee RK; Abnous K; Ramezani M
Int J Biochem Cell Biol; 2017 Nov; 92():210-217. PubMed ID: 29031805
[TBL] [Abstract][Full Text] [Related]
36. Synthetic Polymer Hybridization with DNA and RNA Directs Nanoparticle Loading, Silencing Delivery, and Aptamer Function.
Zhou Z; Xia X; Bong D
J Am Chem Soc; 2015 Jul; 137(28):8920-3. PubMed ID: 26138550
[TBL] [Abstract][Full Text] [Related]
37. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2.
Wullner U; Neef I; Eller A; Kleines M; Tur MK; Barth S
Curr Cancer Drug Targets; 2008 Nov; 8(7):554-65. PubMed ID: 18991566
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic insights into LDL nanoparticle-mediated siRNA delivery.
Jin H; Lovell JF; Chen J; Lin Q; Ding L; Ng KK; Pandey RK; Manoharan M; Zhang Z; Zheng G
Bioconjug Chem; 2012 Jan; 23(1):33-41. PubMed ID: 22142191
[TBL] [Abstract][Full Text] [Related]
39. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
40. Dendrimer Nanovectors for SiRNA Delivery.
Liu X; Peng L
Methods Mol Biol; 2016; 1364():127-42. PubMed ID: 26472447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
